Cargando…

M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation

Abnormal immune regulation is a key feature of the complex pathogenic mechanism of ulcerative colitis (UC). In particular, macrophages and group 2 innate lymphoid cells (ILC2s) are important components of natural immunity that have been shown to play important roles in the pathogenesis of UC, as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiaxi, Liu, Deliang, Tan, Yuyong, Deng, Feihong, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957199/
https://www.ncbi.nlm.nih.gov/pubmed/33569850
http://dx.doi.org/10.1111/jcmm.16348
_version_ 1783664604074737664
author Lu, Jiaxi
Liu, Deliang
Tan, Yuyong
Deng, Feihong
Li, Rong
author_facet Lu, Jiaxi
Liu, Deliang
Tan, Yuyong
Deng, Feihong
Li, Rong
author_sort Lu, Jiaxi
collection PubMed
description Abnormal immune regulation is a key feature of the complex pathogenic mechanism of ulcerative colitis (UC). In particular, macrophages and group 2 innate lymphoid cells (ILC2s) are important components of natural immunity that have been shown to play important roles in the pathogenesis of UC, as well as decreased E‐cadherin expression on the colonic mucosa. However, it remains unclear how these components interact with each other. In this study, we investigated the molecular mechanisms of UC mediated by macrophage‐derived exosomes. We showed for the first time that miR‐21a‐5p expression is increased in the peritoneal exosomes of mice with dextran sulphate sodium induced enteritis and that miR‐21a‐5p expression correlates negatively with E‐cadherin expression in enterocytes. Moreover, we confirmed that miR‐21a‐5p was mainly derived from M1 macrophages and demonstrated that KLRG1, a surface inhibitory receptor on ILC2s, participated in excessive ILC2 activation in UC by promoting GATA‐3. In conclusion, our results suggest molecular targets and provide a theoretical basis for elucidating the pathogenesis of UC and improving its treatment.
format Online
Article
Text
id pubmed-7957199
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79571992021-03-19 M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation Lu, Jiaxi Liu, Deliang Tan, Yuyong Deng, Feihong Li, Rong J Cell Mol Med Original Articles Abnormal immune regulation is a key feature of the complex pathogenic mechanism of ulcerative colitis (UC). In particular, macrophages and group 2 innate lymphoid cells (ILC2s) are important components of natural immunity that have been shown to play important roles in the pathogenesis of UC, as well as decreased E‐cadherin expression on the colonic mucosa. However, it remains unclear how these components interact with each other. In this study, we investigated the molecular mechanisms of UC mediated by macrophage‐derived exosomes. We showed for the first time that miR‐21a‐5p expression is increased in the peritoneal exosomes of mice with dextran sulphate sodium induced enteritis and that miR‐21a‐5p expression correlates negatively with E‐cadherin expression in enterocytes. Moreover, we confirmed that miR‐21a‐5p was mainly derived from M1 macrophages and demonstrated that KLRG1, a surface inhibitory receptor on ILC2s, participated in excessive ILC2 activation in UC by promoting GATA‐3. In conclusion, our results suggest molecular targets and provide a theoretical basis for elucidating the pathogenesis of UC and improving its treatment. John Wiley and Sons Inc. 2021-02-10 2021-03 /pmc/articles/PMC7957199/ /pubmed/33569850 http://dx.doi.org/10.1111/jcmm.16348 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lu, Jiaxi
Liu, Deliang
Tan, Yuyong
Deng, Feihong
Li, Rong
M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
title M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
title_full M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
title_fullStr M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
title_full_unstemmed M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
title_short M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
title_sort m1 macrophage exosomes mir‐21a‐5p aggravates inflammatory bowel disease through decreasing e‐cadherin and subsequent ilc2 activation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957199/
https://www.ncbi.nlm.nih.gov/pubmed/33569850
http://dx.doi.org/10.1111/jcmm.16348
work_keys_str_mv AT lujiaxi m1macrophageexosomesmir21a5paggravatesinflammatoryboweldiseasethroughdecreasingecadherinandsubsequentilc2activation
AT liudeliang m1macrophageexosomesmir21a5paggravatesinflammatoryboweldiseasethroughdecreasingecadherinandsubsequentilc2activation
AT tanyuyong m1macrophageexosomesmir21a5paggravatesinflammatoryboweldiseasethroughdecreasingecadherinandsubsequentilc2activation
AT dengfeihong m1macrophageexosomesmir21a5paggravatesinflammatoryboweldiseasethroughdecreasingecadherinandsubsequentilc2activation
AT lirong m1macrophageexosomesmir21a5paggravatesinflammatoryboweldiseasethroughdecreasingecadherinandsubsequentilc2activation